Definitive Capital Surpluse from 2010 to 2025

DH Stock  USD 5.19  0.27  5.49%   
Definitive Healthcare's Capital Surpluse is decreasing with slightly volatile movements from year to year. Capital Surpluse is predicted to flatten to about 712.6 M. For the period between 2010 and 2025, Definitive Healthcare, Capital Surpluse quarterly trend regression had mean deviation of  29,226,881 and range of 178.1 M. View All Fundamentals
 
Capital Surpluse  
First Reported
2010-12-31
Previous Quarter
801.7 M
Current Value
712.6 M
Quarterly Volatility
48.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Definitive Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Definitive Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 57.6 M, Interest Expense of 16.7 M or Selling General Administrative of 35.5 M, as well as many indicators such as Price To Sales Ratio of 4.87, Dividend Yield of 0.0104 or PTB Ratio of 1.42. Definitive financial statements analysis is a perfect complement when working with Definitive Healthcare Valuation or Volatility modules.
  
Check out the analysis of Definitive Healthcare Correlation against competitors.

Currently Active Assets on Macroaxis

Check out the analysis of Definitive Healthcare Correlation against competitors.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Definitive Healthcare. If investors know Definitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.09)
Revenue Per Share
2.187
Quarterly Revenue Growth
(0.04)
Return On Assets
(0.01)
Return On Equity
(0.55)
The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Definitive Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Definitive Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Definitive Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.